**PCI Biotech Begins Evaluation of Structured Wind-Up Process**
Oslo, Norway – PCI Biotech (OSE: PCIB) has announced the start of an evaluation process to consider a structured wind-up of the company. This follows the decision to discontinue all research and development activities, as previously communicated on 8 January 2026. The company is continuing to explore strategic alternatives while …